These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34959715)

  • 1. Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.
    Matheson J; Zhou XMM; Bourgault Z; Le Foll B
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.
    Kinsey SG; Long JZ; Cravatt BF; Lichtman AH
    J Pain; 2010 Dec; 11(12):1420-8. PubMed ID: 20554481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety associated with palatable food withdrawal is reversed by the selective FAAH inhibitor PF-3845: A regional analysis of the contribution of endocannabinoid signaling machinery.
    de Ceglia M; Micioni Di Bonaventura MV; Romano A; Friuli M; Micioni Di Bonaventura E; Gavito AL; Botticelli L; Gaetani S; de Fonseca FR; Cifani C
    Int J Eat Disord; 2023 Jun; 56(6):1098-1113. PubMed ID: 36840536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid metabolism inhibition ameliorates ovalbumin-induced allergic airway inflammation and hyperreactivity in Guinea pigs.
    Abohalaka R; Karaman Y; Recber T; Onder SC; Nemutlu E; Bozkurt TE
    Life Sci; 2022 Oct; 306():120808. PubMed ID: 35843343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors.
    van Egmond N; Straub VM; van der Stelt M
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():441-463. PubMed ID: 32867595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
    Tuo W; Leleu-Chavain N; Spencer J; Sansook S; Millet R; Chavatte P
    J Med Chem; 2017 Jan; 60(1):4-46. PubMed ID: 27766867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
    Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.
    Rodriguez-Sanchez IP; Guindon J; Ruiz M; Tejero ME; Hubbard G; Martinez-de-Villarreal LE; Barrera-Saldaña HA; Dick EJ; Comuzzie AG; Schlabritz-Loutsevitch NE
    Neurotoxicol Teratol; 2016; 58():23-30. PubMed ID: 27327781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
    Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S
    Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
    Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
    Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral endocannabinoid system dysregulation in first-episode psychosis.
    Bioque M; García-Bueno B; Macdowell KS; Meseguer A; Saiz PA; Parellada M; Gonzalez-Pinto A; Rodriguez-Jimenez R; Lobo A; Leza JC; Bernardo M;
    Neuropsychopharmacology; 2013 Dec; 38(13):2568-77. PubMed ID: 23822951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
    Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
    ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors.
    Ren SY; Wang ZZ; Zhang Y; Chen NH
    Acta Pharmacol Sin; 2020 Oct; 41(10):1263-1271. PubMed ID: 32203086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.